Finance

Lists
Why is LUNG up 2,46%?
Dive Deeper
LUNG:NASDAQ
Pulmonx Corp
1,88 USD
+2,46%
(+0,045) 1D
5-окт., 11:44:22 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LUNG...
Open
1,85 USD
High
1,92 USD
Low
1,80 USD
Mkt. cap
80,53 млн
Avg. vol.
311,16 миң
Volume
107,92 миң
52-wk high
2,89 USD
52-wk low
1,13 USD
EPS
-1,16 USD
Beta
0,33
Shares outstanding
42,95 млн
No. of employees
296
Open
1,85 USD
High
1,92 USD
Low
1,80 USD
Mkt. cap
80,53 млн
Avg. vol.
311,16 миң
Volume
107,92 миң
52-wk high
2,89 USD
52-wk low
1,13 USD
EPS
-1,16 USD
Beta
0,33
Shares outstanding
42,95 млн
No. of employees
296
News stories
From web sources and news partners
About Pulmonx Corp
CEO-
Employees296
Founded1995
HeadquartersРедвуд Сити, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Websitepulmonx.com
Analyst ratings
Based on 4 analysts giving stock ratings to LUNG in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for LUNG in the last 3 months.
Highest
Current 1,88 USD
5,00 USD (+166,67%)
Average
3,50 USD (+86,67%)
Lowest
2,50 USD (+33,33%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Young CFA
Canaccord Genuity
Buy
Maintained
5,00 USD
+166,7%
08/11/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
2,50 USD
+33,3%
07/30/2026
Frank Takkinen
Lake Street
Buy
Reiterated
4,00 USD
+113,3%
07/30/2026
Jason Bednar
Piper Sandler
Hold
Maintained
2,50 USD
+33,3%
07/30/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
5,00 USD
+166,7%
04/30/2026
Last report
2026-ж., 29-июл.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,24 USD / -0,28 USD
+14,29%beat
Revenue / Est. (USD)
22,76 млн / 22,50 млн
+1,14%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
21,50 млн
22,60 млн
20,59 млн
22,76 млн
Cost of goods sold
5,45 млн
5,06 млн
4,54 млн
5,01 млн
Cost of revenue
5,45 млн
5,06 млн
4,54 млн
5,01 млн
Research and development expenses
4,85 млн
4,58 млн
4,90 млн
5,03 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25,60 млн
22,86 млн
24,10 млн
21,76 млн
Operating expense
30,44 млн
27,44 млн
29,00 млн
26,80 млн
Total operating expenses
35,90 млн
32,50 млн
33,54 млн
31,81 млн
Operating income
-14,39 млн
-9,90 млн
-12,96 млн
-9,06 млн
Other non operating income
-42,00 миң
81,00 миң
277,00 миң
99,00 миң
EBT including unusual items
-13,83 млн
-10,24 млн
-13,50 млн
-9,95 млн
EBT excluding unusual items
-13,83 млн
-10,24 млн
-13,50 млн
-9,95 млн
Income tax expense
128,00 миң
186,00 миң
149,00 миң
133,00 миң
Effective tax rate
-0,93%
-1,82%
-1,10%
-1,34%
Other operating expenses
-
-
-
-
Net income
-13,96 млн
-10,42 млн
-13,65 млн
-10,08 млн
Net profit margin
-64,91%
-46,13%
-66,33%
-44,30%
Earnings per share
-0,34
-0,25
-0,33
-0,24
Interest and investment income
611,00 миң
453,00 миң
350,00 миң
329,00 миң
Interest expense
-805,00 миң
-770,00 миң
-976,00 миң
-1,22 млн
Net interest expenses
-194,00 миң
-317,00 миң
-626,00 миң
-889,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,25 млн
-9,57 млн
-12,84 млн
-8,84 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору